MedTrace Logo

Clinical Outcomes for Offering Genetic Testing in a Tiered Approach

NCT04902144 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2023-06-09

Study results available
· View outcomes & findings →

Summary

This clinical quality improvement study reviews and develops a clinical operations workflow to identify cancer patients who meet criteria for genetic counseling and testing. This study may improve utilization of genetic counseling and testing amongst community-based oncology providers caring for cancer patients in a rural and underserved area.

Conditions

  • Breast Carcinoma
  • Colon Carcinoma
  • Malignant Solid Neoplasm
  • Ovarian Carcinoma
  • Pancreatic Carcinoma
  • Prostate Carcinoma

Interventions

OTHER

Electronic Health Record Review

Medical data collected

OTHER

Questionnaire Administration

Complete questionnaires

BEHAVIORAL

Behavioral Intervention

Receive coaching

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Fred Hutchinson Cancer Center

    lead OTHER

Principal Investigators

  • Marianne Dubard-Gault · Fred Hutch/University of Washington Cancer Consortium

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-03
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04902144 on ClinicalTrials.gov